| Product Code: ETC8633675 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Psoriasis Therapeutics Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Psoriasis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Psoriasis Therapeutics Market - Industry Life Cycle |
3.4 Nigeria Psoriasis Therapeutics Market - Porter's Five Forces |
3.5 Nigeria Psoriasis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Nigeria Psoriasis Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Nigeria Psoriasis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about psoriasis and its treatment options in Nigeria |
4.2.2 Growing prevalence of psoriasis in Nigeria |
4.2.3 Rising healthcare expenditure and government initiatives to improve healthcare infrastructure |
4.2.4 Introduction of advanced therapies and treatment options for psoriasis in the market |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas of Nigeria |
4.3.2 High cost of psoriasis treatment and medications |
4.3.3 Lack of skilled healthcare professionals specialized in psoriasis care in Nigeria |
5 Nigeria Psoriasis Therapeutics Market Trends |
6 Nigeria Psoriasis Therapeutics Market, By Types |
6.1 Nigeria Psoriasis Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Psoriasis Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Nigeria Psoriasis Therapeutics Market Revenues & Volume, By Plaque Psoriasis, 2021- 2031F |
6.1.4 Nigeria Psoriasis Therapeutics Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2 Nigeria Psoriasis Therapeutics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Psoriasis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Nigeria Psoriasis Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Nigeria Psoriasis Therapeutics Market Revenues & Volume, By Topical, 2021- 2031F |
7 Nigeria Psoriasis Therapeutics Market Import-Export Trade Statistics |
7.1 Nigeria Psoriasis Therapeutics Market Export to Major Countries |
7.2 Nigeria Psoriasis Therapeutics Market Imports from Major Countries |
8 Nigeria Psoriasis Therapeutics Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed psoriasis treatment regimens |
8.2 Number of healthcare facilities offering specialized psoriasis treatment services |
8.3 Rate of adoption of new psoriasis treatment options and therapies |
8.4 Patient satisfaction and improvement in quality of life after receiving psoriasis treatment |
8.5 Number of clinical trials and research studies conducted on psoriasis treatment in Nigeria |
9 Nigeria Psoriasis Therapeutics Market - Opportunity Assessment |
9.1 Nigeria Psoriasis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Nigeria Psoriasis Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Nigeria Psoriasis Therapeutics Market - Competitive Landscape |
10.1 Nigeria Psoriasis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Psoriasis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |